News | May 08, 2023
Galmed Pharmaceuticals forms partnership with OnKai
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Pheezee is designed to assess musculoskeletal and neuromuscular health.
Nous-209 has been developed using the Nouscom's viral vector platform
New agreement applies to the polymers of the Medical Care series portfolio
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
Subscribe To Our Newsletter & Stay Updated
